Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 3 2Phase 2 2Phase 1 2Phase NA 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 88Carcinoma, Non-Small-Cell Lung 86Multiple Myeloma 73Prostatic Neoplasms 63Neoplasms 55Colorectal Neoplasms 46Lymphoma 42Squamous Cell Carcinoma of Head and Neck 41Leukemia, Myeloid, Acute 41Lung Neoplasms 39Pancreatic Neoplasms 32Neoplasm Metastasis 32Carcinoma, Hepatocellular 31Ovarian Neoplasms 30Lymphoma, Large B-Cell, Diffuse 29Carcinoma, Renal Cell 29Urinary Bladder Neoplasms 28Lymphoma, Non-Hodgkin 27Melanoma 26Head and Neck Neoplasms 26Hematologic Neoplasms 25Triple Negative Breast Neoplasms 24Sarcoma 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Hodgkin Disease 23Leukemia, Lymphocytic, Chronic, B-Cell 22Glioma 22Stomach Neoplasms 20Myelodysplastic Syndromes 20Lymphoma, Mantle-Cell 19

Interventions

Prednisone 2niraparib 1Docetaxel 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Prostatic Neoplasms, Castration-Resistant × 30 days × Clear all
NCT05848011 2026-05-22

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

MacroGenics

Phase 2 Completed
154 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT03431350 2026-05-11

QUEST

Janssen Research & Development, LLC

Phase 2 Active not recruiting
136 enrolled 29 charts
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡